Net Cash Provided by (Used in) Operating Activities |
2.77B |
USD |
-10% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
6.1B |
USD |
+21.1% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-7.72B |
USD |
+17.1% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
3.2B |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.15B |
USD |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.98B |
USD |
-5.71% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
631M |
USD |
+21.6% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
266M |
USD |
+10.8% |
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Operating Lease, Liability |
387M |
USD |
-6.07% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
6.02B |
USD |
-5.17% |
Q2 2025 |
Q2 2025 |
Property, Plant and Equipment, Gross |
184B |
USD |
+9.25% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-400M |
USD |
-201% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
233M |
USD |
-11.1% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
5.37B |
USD |
-13.2% |
Q4 2024 |
FY 2024 |